{"id":51933,"date":"2022-12-13T22:02:57","date_gmt":"2022-12-13T21:02:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/"},"modified":"2022-12-13T22:02:57","modified_gmt":"2022-12-13T21:02:57","slug":"diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/","title":{"rendered":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Industry veteran Manu Diwakar joins as Chief Financial Officer, and longtime Virta leader Lucia Guillory is promoted to Chief People Officer<\/i>\n<\/p>\n<p>DENVER&#8211;(BUSINESS WIRE)&#8211;Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/5\/CFO-OG-Announcement_%283%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663913\/5\/Virta_Logo_-_White_on_Blue.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663913\/21\/Virta_Logo_-_White_on_Blue.jpg\"><\/a><\/p>\n<p>\nWith nearly two decades of industry experience, Manu Diwakar joins as Chief Financial Officer (CFO). Before Virta, Diwakar served as CFO at virtual musculoskeletal treatment company Kaia Health. Diwakar has also held top leadership roles at Ceres Imaging, Victorious (acquired by Headspace), and Riot Games (acquired by Tencent), where he helped Riot scale from 150 to 2000 employees while growing revenue from &lt;$50 million to more than $1 billion per year.\n<\/p>\n<p>\nLucia Guillory, who joined as Virta\u2019s Head of People and Places in 2019, has been named Chief People Officer. During her tenure, Guillory scaled hiring to support increasing demand\u2014nearly tripling headcount in the last three years\u2014while building a strong internal culture, earning accolades such as <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.inc.com%2Fprofile%2Fvirta-health&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=Inc.%26%238217%3Bs+Best+Places+to+Work&amp;index=1&amp;md5=9aecae4f75cbb4ec28e017be6956d538\" rel=\"nofollow noopener\" shape=\"rect\">Inc.\u2019s Best Places to Work<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffortune.com%2Fbest-small-workplaces-health-care%2F2022%2Fvirta-health%2F&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=Fortune%26%238217%3Bs+Best+Workplaces+in+Health+Care&amp;index=2&amp;md5=674918d58af9b779a9b6e99b0c1e5d4d\" rel=\"nofollow noopener\" shape=\"rect\">Fortune\u2019s Best Workplaces in Health Care<\/a>.\n<\/p>\n<p>\nBoth appointments support Virta\u2019s continuing growth alongside a broader, industry-wide shift toward chronic disease reversal. Amid a perfect storm of skyrocketing drug prices, employee health costs, and rates of metabolic disease, patients and payers alike are turning to Virta as the antidote.\n<\/p>\n<p>\nOver the past 12 months, key milestones include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Triple-digit year-over-year customer growth:<\/b> Virta now partners with more than 350 large employers, health plans, and government organizations, including <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhumananews.com%2Fnews-details%2F2021%2FHumana-and-Virta-Health-Team-Up-to-Bring-Type-2-Diabetes-Reversal-Treatment-to-Humana-Employer-Group-Members%2Fdefault.aspx&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=Humana&amp;index=3&amp;md5=f2712387b38b7855ef23626705116221\" rel=\"nofollow noopener\" shape=\"rect\">Humana<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.banneraetna.com%2Fen%2Fabout-us%2Fnews%2Fpartners-with-virta-health.html&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=Banner%7CAetna&amp;index=4&amp;md5=88e8c1cf8865be76af4c515715b24ca6\" rel=\"nofollow noopener\" shape=\"rect\">Banner|Aetna<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.virtahealth.com%2Fblog%2Fu-haul-team-members-enrolled-with-virta-health-eliminate-over-one-third-of-diabetes-medications-in-just-90-days&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=U-Haul&amp;index=5&amp;md5=10fa068d358c7dadf7ef5e66b819c7de\" rel=\"nofollow noopener\" shape=\"rect\">U-Haul<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.virtahealth.com%2Fblog%2Fautozone-virta&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=AutoZone&amp;index=6&amp;md5=1078e76487b7428763694191bed668fe\" rel=\"nofollow noopener\" shape=\"rect\">AutoZone<\/a>.\n<\/li>\n<li>\n<b>Doubling patient enrollment: <\/b>Industry-leading patient outcomes\u2014from long-term blood sugar control to clinically significant weight loss to medication reduction and elimination\u2014have continued to drive strong demand for Virta\u2019s care model and approach.\n<\/li>\n<li>\n<b>New research: <\/b>Virta added four peer-reviewed papers in 2022, in part highlighting improvement in both depression symptoms and knee pain for patients. The company also reported <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.virtahealth.com%2Fblog%2Fvirta-sustainable-health-improvements-5-year-diabetes-reversal-study&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=5-year+clinical+trial+results&amp;index=7&amp;md5=2a031fa195cd759e31c99fdbda4e6a89\" rel=\"nofollow noopener\" shape=\"rect\">5-year clinical trial results<\/a> at the ADA\u2019s 82nd Scientific Sessions in June, and recently shared <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.virtahealth.com%2Fblog%2Faddressing-disparities-type-2-diabetes&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=health+equity+research&amp;index=8&amp;md5=e975d0d8bec90183135026fcce43b568\" rel=\"nofollow noopener\" shape=\"rect\">health equity research<\/a> on the impact of its treatment across diverse racial, ethnic and socioeconomic groups.\n<\/li>\n<li>\n<b>Outcomes and cost savings validation: <\/b>Virta received Validation Institute\u2019s Program Validation, recognizing its best-in-class <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvalidationinstitute.com%2Fwp-content%2Fuploads%2F2021%2F01%2FVirta-Health-final.pdf&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=health&amp;index=9&amp;md5=15812a4e3e9468e93021daca87f225fa\" rel=\"nofollow noopener\" shape=\"rect\">health<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvalidationinstitute.com%2Fwp-content%2Fuploads%2F2022%2F03%2FVirta-Health-2022-Final.pdf&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=financial+outcomes&amp;index=10&amp;md5=ef121f3935bc41ff4b728b91358dc204\" rel=\"nofollow noopener\" shape=\"rect\">financial outcomes<\/a> for employer customers, including industry-leading prescription drug savings.\n<\/li>\n<li>\n<b>Launched Road to Reversal movement:<\/b> Patients across the country are sharing how <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.virtahealth.com%2Froad-to-reversal&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=diabetes+reversal+transformed+their+health&amp;index=11&amp;md5=d69f85df19ced5bc24f879d536763267\" rel=\"nofollow noopener\" shape=\"rect\">diabetes reversal transformed their health<\/a>. Just a few examples include Brandon, who eliminated all medications\u2014including his antidepressants, Michael, who lost over 200 pounds, and Elissa, who can run around with her children again. For these patients, reversal means turning back the clock on diabetes and getting their lives back.\n<\/li>\n<\/ul>\n<p>\n\u201cVirta\u2019s solution is unique because it works\u2014and it works without caveats,\u201d said Manu Diwakar, Virta\u2019s CFO. \u201cThere is no opportunity to make a bigger impact in U.S. healthcare than in scaling this solution so we can reach even more patients and payers.\u201d\n<\/p>\n<p>\nGuillory echoed this sentiment: \u201cI have a personal connection to diabetes, and have seen what this disease can do to people and their families on a daily basis. I want to see this disease eradicated\u2014and Virta is showing this could be possible. We&#8217;re helping people get their lives back.\u201d\n<\/p>\n<p>\n<b><span class=\"bwuline\">About Virta Health<\/span><\/b>\n<\/p>\n<p>\nVirta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by nearly 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.virtahealth.com&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=www.virtahealth.com&amp;index=12&amp;md5=d33dd98606de3165606b0965d47a5945\" rel=\"nofollow noopener\" shape=\"rect\">www.virtahealth.com<\/a> or follow us on Twitter <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fvirtahealth&amp;esheet=53058741&amp;newsitemid=20221213006006&amp;lan=en-US&amp;anchor=%40virtahealth&amp;index=13&amp;md5=eb5906a6cc74d2aa0e23fa70e6a3e9ef\" rel=\"nofollow noopener\" shape=\"rect\">@virtahealth<\/a>.\u00a0\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nLauren Cunningham<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x4c;a&#x75;&#114;&#x65;&#110;&#46;&#x63;&#117;&#x6e;&#110;i&#x6e;g&#x68;&#97;&#x6d;&#64;v&#x69;r&#x74;&#97;&#x68;&#x65;a&#x6c;&#116;&#x68;&#46;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#76;&#x61;&#117;&#x72;&#101;&#x6e;&#46;&#x63;&#117;&#x6e;&#110;&#x69;&#110;&#x67;&#104;&#x61;&#109;&#x40;&#118;&#x69;&#114;&#x74;&#97;&#x68;&#101;&#x61;&#108;&#x74;&#104;&#x2e;&#99;&#x6f;&#109;<\/a><br \/>831-331-3307\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Industry veteran Manu Diwakar joins as Chief Financial Officer, and longtime Virta leader Lucia Guillory is promoted to Chief People Officer DENVER&#8211;(BUSINESS WIRE)&#8211;Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions. With nearly two decades of industry &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51933","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Industry veteran Manu Diwakar joins as Chief Financial Officer, and longtime Virta leader Lucia Guillory is promoted to Chief People Officer DENVER&#8211;(BUSINESS WIRE)&#8211;Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions. With nearly two decades of industry ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-13T21:02:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth\",\"datePublished\":\"2022-12-13T21:02:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/\"},\"wordCount\":664,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213006006\\\/en\\\/1663914\\\/21\\\/CFO-OG-Announcement_%283%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/\",\"name\":\"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213006006\\\/en\\\/1663914\\\/21\\\/CFO-OG-Announcement_%283%29.jpg\",\"datePublished\":\"2022-12-13T21:02:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213006006\\\/en\\\/1663914\\\/21\\\/CFO-OG-Announcement_%283%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221213006006\\\/en\\\/1663914\\\/21\\\/CFO-OG-Announcement_%283%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/","og_locale":"en_US","og_type":"article","og_title":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend","og_description":"Industry veteran Manu Diwakar joins as Chief Financial Officer, and longtime Virta leader Lucia Guillory is promoted to Chief People Officer DENVER&#8211;(BUSINESS WIRE)&#8211;Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions. With nearly two decades of industry ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-13T21:02:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth","datePublished":"2022-12-13T21:02:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/"},"wordCount":664,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/","url":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/","name":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg","datePublished":"2022-12-13T21:02:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221213006006\/en\/1663914\/21\/CFO-OG-Announcement_%283%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/diabetes-reversal-leader-virta-health-deepens-executive-bench-amid-triple-digit-year-over-year-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51933"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51933\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}